Interviews with authors of articles from JAMA Neurology. JAMA Neurology is an international peer-reviewed journal for physicians caring for people with neurologic disorders and those interested in the structure and function of the normal and diseased nervous system.
126 - Phenoconversion in Pure Autonomic Failure
00:00
00:00
Interviews with authors of articles from JAMA Neurology. JAMA Neurology is an international peer-reviewed journal for physicians caring for people with neurologic disorders and those interested in the structure and function of the normal and diseased nervous system.
Episodes
126-
Phenoconversion in Pure Autonomic Failure
Listened
Mon, 04 May 2026
125-
Brain Biomarkers and a Multidomain Lifestyle Intervention
Listened
Mon, 20 Apr 2026
124-
Epstein-Barr Virus Antibodies and Multiple Sclerosis
Listened
Mon, 09 Mar 2026
123-
Comparative Effectiveness of Brivaracetam, Cenobamate,Lacosamide, and Perampanel in Focal Epilepsy
Listened
Mon, 09 Feb 2026
122-
US Burden of Disorders Affecting the Nervous System
Listened
Mon, 24 Nov 2025
121-
Hemorrhage and Risk Factors in Unruptured Brain AVM
Listened
Mon, 06 Oct 2025
120-
Intravenous Argatroban or Eptifibatide and Mechanical Thrombectomy
Listened
Mon, 18 Aug 2025
119-
GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension
Listened
Mon, 14 Jul 2025
118-
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome
Listened
Mon, 02 Jun 2025
117-
Fremanezumab for the Treatment of Migraine and Major Depressive Disorder
Listened
Mon, 05 May 2025
116-
Optimal Delay Time to Initiate Anticoagulation After AF-Associated Ischemic Stroke
Listened
Mon, 31 Mar 2025
115-
Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage
Listened
Mon, 03 Mar 2025
114-
Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine
Listened
Mon, 06 Jan 2025
113-
β-Blocker Use and Delayed Onset and Progression of Huntington Disease
Listened
Mon, 02 Dec 2024
112-
Alzheimer Disease as a Clinical-Biological Construct
Listened
Fri, 01 Nov 2024
111-
Perceived CTE in Former Professional Football Players
Listened
Mon, 23 Sep 2024
110-
Localized Nicardipine Release Implants for Prevention of Vasospasm
Listened
Mon, 19 Aug 2024
109-
Direct-Acting OACs and Antiseizure Medications for AF and Epilepsy and Risk of Thromboembolic Events
Listened
Mon, 08 Jul 2024
108-
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation
Listened
Tue, 28 May 2024
107-
Association of New-Onset Seizures With SARS-CoV-2 Vaccines
Listened
Mon, 29 Apr 2024
106-
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS
Listened
Mon, 25 Mar 2024
105-
Posttraumatic Epilepsy and Dementia Risk
Listened
Mon, 26 Feb 2024
104-
Risk of Stroke and Myocardial Infarction Among Initiators of Triptans
Listened
Mon, 05 Feb 2024
103-
Risk Factors for Young-Onset Dementia in the UK Biobank
Listened
Tue, 26 Dec 2023
102-
Endovascular Therapy Outcomes by ASPECTS and Infarct Core Volume in Patients With Large Infarct
Listened
Mon, 27 Nov 2023
101-
Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis
Listened
Mon, 06 Nov 2023
100-
Atrial Fibrillation In Patients With Stroke Attributed to Large- or Small-Vessel Disease
Listened
Mon, 30 Oct 2023
99-
Neuropathologic and Clinical Findings in Athletes With Repetitive Head Impacts
Listened
Mon, 28 Aug 2023
98-
Dementia Risk and Disadvantaged Neighborhoods
Listened
Wed, 19 Jul 2023
97-
Automated Interpretation of Clinical Electroencephalograms Using Artificial Intelligence
Listened
Tue, 20 Jun 2023
96-
Risk of Parkinson Disease Among Camp Lejeune Veterans
Listened
Mon, 15 May 2023
95-
Prenatal Exposure to Antiseizure Medication and Psychiatric Disorders
Listened
Mon, 17 Apr 2023
94-
Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk Factors
Listened
Mon, 27 Mar 2023
93-
Optimal Intensity and Duration of Walking Rehabilitation in Patients With Chronic Stroke
Listened
Thu, 23 Feb 2023
92-
Endovascular Thrombectomy vs Medical Management Beyond 24 Hours of Last Known Well
Listened
Tue, 27 Dec 2022
91-
Autoimmune Encephalitis Misdiagnosis in Adults
Listened
Mon, 28 Nov 2022
90-
Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease
Listened
Mon, 31 Oct 2022
89-
Cancer Risk in Children of Mothers With Epilepsy and High-Dose Folic Acid Use During Pregnancy
Listened
Mon, 26 Sep 2022
88-
Association of Neurocritical Care With Outcomes for Adults With Brain Injury
Listened
Mon, 29 Aug 2022
87-
Efficacy of Benzodiazepines or Antihistamines for Patients With Acute Vertigo
Listened
Mon, 18 Jul 2022
86-
A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief
Listened
Tue, 05 Jul 2022
85-
Structural Inequities for Historically Underserved Communities in the Adoption of Stroke Certification in the US
Listened
Mon, 27 Jun 2022
84-
Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability
Listened
Tue, 31 May 2022
83-
Postmortem Assessment of Olfactory Tissue Degeneration and Microvasculopathy in Patients With COVID-19
Listened
Mon, 11 Apr 2022
82-
Early Posttraumatic Seizures and Moderate to Severe Traumatic Brain Injury
Listened
Mon, 21 Feb 2022
81-
Infarct on Brain Imaging, Subsequent Ischemic Stroke, and Clopidogrel-Aspirin Efficacy
Listened
Tue, 18 Jan 2022
80-
Assessment of Erenumab Safety and Efficacy in Migraine With and Without Aura
Listened
Mon, 20 Dec 2021
79-
Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Probable Dementia With Lewy Bodies
Listened
Mon, 22 Nov 2021
78-
Association of Increased Seizures During Rewarming With Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up
Listened
Mon, 18 Oct 2021
77-
Use and Safety of Immunotherapeutic Management of N-Methyl-D-Aspartate Receptor Antibody Encephalitis